S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Liu, Huamin ^a   Wang, Lei ^a   Wang, Xingang ^a   Cao, Zhiwei ^b   Yang, Qifeng ^b   Zhang, Kejun ^a  

^a QINGDAO UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Breast cancer; Invasion; S100A7,NF B

Indexed keywords

COMPLEMENTARY DNA; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN S 100; PROTEIN S 100 A7; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL INVASION; CELL PROLIFERATION; DNA BINDING; DOWN REGULATION; ELECTROPHORETIC MOBILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; TUMOR INVASION; UPREGULATION;

APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; RECEPTOR, NOTCH1; RNA, SMALL INTERFERING; S100 PROTEINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876738280     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-93     Document Type: Article

References (28)

1. Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, Niu Y. Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 1999, 155:2057-2066. 10.1016/S0002-9440(10)65524-1, 1866920, 10595935.
2. Enerback C, Porter DA, Seth P, Sgroi D, Gaudet J, Weremowicz S. Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res 2002, 62:43-47.
3. Emberley ED, Murphy LC, Watson PH. S100A7 and the progression of breast cancer. Breast Cancer Res 2004, 6:153-159. 10.1186/bcr816, 468668, 15217486.
4. Emberley ED, Niu Y, Leygue E, Tomes L, Gietz RD, Murphy LC. Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res 2003, 63:1954-1961.
5. Emberley ED, Niu Y, Njue C, Kliewer EV, Murphy LC, Watson PH. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. Clin Cancer Res 2003, 9:2627-2631.
6. Krop I, Marz A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M. A putative role for psoriasin in breast tumor progression. Cancer Res 2005, 65:11326-11334. 10.1158/0008-5472.CAN-05-1523, 16357139.
7. Emberley ED, Niu Y, Curtis L, Troup S, Mandal SK, Myers JN. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer. Cancer Res 2005, 65:5696-5702. 10.1158/0008-5472.CAN-04-3927, 15994944.
8. Paruchuri V, Prasad A, McHugh K, Bhat HK, Polyak K, Ganju RK. S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation. PLoS One 2008, 3:e1741. 10.1371/journal.pone.0001741, 2254193, 18320059.
9. West NR, Watson PH. S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer. Oncogene 2010, 29:2083-2092. 10.1038/onc.2009.488, 20101226.
10. Nasser MW, Qamri Z, Deol YS, Ravi J, Powell CA, Trikha P, Schwendener RA, Bai XF, Shilo K, Zou X, Leone G, Wolf R, Yuspa SH. Ganju RK.S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Res 2012, 72:604-615. 10.1158/0008-5472.CAN-11-0669, 3271140, 22158945.
11. Pan Q, Bao LW, Merajver SD. Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFkappa B signaling cascade. Mol Cancer Res 2003, 1:701-706.
12. Patel S, Leal AD, Gorski DH. The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-kappa B-dependent endothelial cell gene expression. Cancer Res 2005, 65:1414-1424. 10.1158/0008-5472.CAN-04-3431, 15735029.
13. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB, Iglehart JD. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci U S A 2004, 101:10137-10142. 10.1073/pnas.0403621101, 454178, 15220474.
14. Singh S, Shi Q, Bailey ST, Palczewski MJ, Pardee AB, Iglehart JD, Biswas DK. Nuclear factor-kappa B activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer. Mol Cancer Ther 2007, 6:1973-1982. 10.1158/1535-7163.MCT-07-0063, 17620428.
15. Shibata A, Nagaya T, Imai T, Funahashi H, Nakao A, Seo H. Inhibition of NF-kappa B activity decreases the VEGF mRNA expression in MDA-MB-468 breast cancer cells. Breast Cancer Res Treat 2002, 73:237-243. 10.1023/A:1015872531675, 12160329.
16. Ling H, Zhang Y, Ng KY, Chew EH. Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res Treat 2011, 126:609-620. 10.1007/s10549-010-0929-5, 20521099.
17. Bryborn M, Adner M, Cardell LO. Psoriasin, one of several new proteins identified in nasal lavage fluid from allergic and non-allergic individuals using 2-dimensional gel electrophoresis and mass spectrometry. Respir Res 2005, 6:118. 10.1186/1465-9921-6-118, 1282590, 16236163.
18. Ahmed A. Prognostic and therapeutic role of nuclear factor-kappa B (NF-kappa B) in breast cancer. J Ayub Med Coll Abbottabad 2010, 22:218-221.
19. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000, 36:1621-1630. 10.1016/S0959-8049(00)00156-8, 10959048.
20. Dong Z, Bonfil RD, Chinni S. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. Am J Pathol 2005, 166:1173-1186. 10.1016/S0002-9440(10)62337-1, 1602391, 15793297.
21. John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001, 7:14-23. 10.1007/BF03032599, 11349215.
22. Kao SJ, Su JL, Chen CK, Yu MC, Bai KJ, Chang JH, Bien MY, Yang SF, Chien MH. Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression. Toxicol Appl Pharmacol 2012, 261:105-115. 10.1016/j.taap.2012.03.020, 22503731.
23. Kang H, Lee M, Choi KC, Shin DM, Ko J, Jang SW. N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell invasion through suppressing NF-KB activation and inhibiting matrix metalloproteinase-9 expression. J Cell Biochem 2012, 113:2845-2855. 10.1002/jcb.24159, 22488409.
24. Dutta S, Wang FQ, Wu HS, Mukherjee TJ, Fishman DA. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC). Gynecol Oncol 2011, 123:129-137. 10.1016/j.ygyno.2011.06.006, 21782227.
25. Nishimura A, Akeda K, Matsubara T, Kusuzaki K, Matsumine A, Masuda K, Gemba T, Uchida A, Sudo A. Transfection of NF-κB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma. Cancer Gene Ther 2011, 18:250-259. 10.1038/cgt.2010.75, 21183950.
26. Greenberger S, Adini I, Boscolo E, Mulliken JB, Bischoff J. Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression. Angiogenesis 2010, 13:327-335. 10.1007/s10456-010-9189-6, 3034388, 20872175.
27. Wong JH, Lui VW, Umezawa K, Ho Y, Wong EY, Ng MH, Cheng SH, Tsang CM, Tsao SW, Chan AT. A small molecule inhibitor of NF-kappa B, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells. Cancer Lett 2010, 287:23-32. 10.1016/j.canlet.2009.05.022, 19560263.
28. Fujioka S, Sclabas GM, Schmidt C. Inhibition of constitutive NF-kB activity by IkBa-M suppresses tumorigenesis. Oncogene 2003, 22:1365-1370. 10.1038/sj.onc.1206323, 12618762.